Drug eruptions at five institutes in Bangkok

Journal of the Medical Association of Thailand

Volumn 88, Issue 11, 2005, Pages 1642-1650

  Puavilai, Siripen ^a   Noppakun, Nopadon ^b   Sitakalin, Chasuree ^c   Leenutaphong, Vichit ^d   Wattanakrai, Penpun ^a   Nakakes, Artit ^c   Kulthanan, Kanokvalai ^d   Asawanonda, Pravit ^b   Akaraphan, Ratsanee ^e   Tresukosol, Poohglin ^e   Suthipinittharm, Puan ^d   Somburanasin, Pitchaya ^a   Charuwichitratana, Somyos ^a   Rajatanavin, Natta ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c Phramongkutklao Hospital and Medical College

^d MAHIDOL UNIVERSITY   (Thailand)

^e Ministry of Public Health

Author keywords

Antimicrobial agents; Drug eruption; Maculopapular rash

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; AZITHROMYCIN; CARBAMAZEPINE; CEFALEXIN; CEFTAZIDIME; CEFTRIAXONE; CELECOXIB; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; GRISEOFULVIN; INSULIN; ISOTRETINOIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENYTOIN; PROPYLTHIOURACIL; SULINDAC; TRAMADOL; UNINDEXED DRUG; ANTIINFLAMMATORY AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ACNE; ADULT; AGED; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; BULLOUS DERMATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ECZEMA; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; FIXED DRUG ERUPTION; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; INFORMED CONSENT; LEUKOCYTOCLASTIC VASCULITIS; LICHENOID; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PUSTULOSIS; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; THAILAND; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; ADOLESCENT; CHEMICALLY INDUCED DISORDER; CHILD; DRUG USE; HOSPITAL PHARMACY; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; RASH; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; DRUG UTILIZATION REVIEW; EXANTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; PROSPECTIVE STUDIES; RISK FACTORS; THAILAND;

EID: 33645238118     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171-3.
2. Katz J. Marmary Y, Livneh A, Danon Y. Drug allergy in Sjogren's syndrome. Lancet 1991; 337: 239.
3. Fiszenson-Albala F, Auzerie V, Mahe E, Farrinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-22.
4. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-4.
5. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug rections. 1. Background, description and instruction for use. JAMA 1979; 242: 623-32.
6. Rademaker M. Do women have more adverse drug reaction? Am J Clin Dermatol 2001; 2: 349-51.
7. Puavilai S, Choonhakarn C. Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital. Int J Dermatol 1998; 37: 747-51.
8. Puavilai S, Kamtavee S, Chunharas A, Pongwiriyapasich S. Drug eruptions: The value of oral rechallenge test and patch test. J Med Assoc Thai 2002; 85: 263-9.
9. Sharma VK, Dhar S. Clinical pattern of cutaneous drug eruption among children and adolescents in north India. Pediatr Dermatol 1995; 12: 178-83.
10. Stubb S, Heikkila H, Kauppinen K. Cutaneous reactions to drugs. A series of in-patients during a five-year period. Acta Dermatol Venereol (Stockh) 1994; 74: 289-91.
11. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765-70.
12. Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell' syndrome). Arch Dermatol 1987; 123: 1166-70.
13. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al, Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. New Engl J Med 1995; 333: 1600-7.
14. Digwood-Lettieri S, Reilly KJ, Haith Jr LR, Patton ML, Guilday RJ, Cawley M J, et al. Levofloxacin-induced toxic epidermal necrolysis in an elderly patient. Pharmacotherapy 2002; 22: 789-93.
15. Stingeni L, Caraffini S, Agostinelli D, Ricci F, Lisi P. Maculopapular and urticarial eruption from cetrizine. Contact Dermatitis 1997; 37: 249-50.
16. Ash S, Scheman AJ. Systemic contact dermatitis to hydroxyzine. Am J Contact Dermat 1997; 8: 2-5.
17. Michel M, Dompmartin A, Louvet S, Szczurko C, Castel B, Leroy D. Skin reactions to hydroxyzine. Contact Dermatitis 1997; 36: 147-9.
18. Karamfilov T, Wilmer A, Hipler UC, Wollina U. Cetirizine-induced urticarial reaction. Br J Dermatol 1999; 140: 979-80.
19. Kranke B, Kern T. Multilocalized fixed drug eruption to the antihistamine cetirizine. J Allergy Clin Immunol 2001; 106: 988.
20. Calista D, Schianchi S, Morri M. Urticaria induced by cetirizine. Br J Dermatol 2001; 144: 196.
21. Schroter S, Damveld B, Marsch WC. Urticarial intolerance reaction to cetirizine. Clin Exp Dermatol 2002; 27: 185-7.
22. Leu BL, Haw CR, Lee MH. Cutaneous drug eruption from cetirizine and hydroxyzine. J Am Acad Dermatol 2004; 50: 953-6.